We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+25.8%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$1.29B
AUM Growth
+$290M
Cap. Flow
+$53.6M
Cap. Flow %
4.15%
Top 10 Hldgs %
55.08%
Holding
1,109
New
59
Increased
171
Reduced
182
Closed
40

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$13.2M
2
MSFT icon
Microsoft
MSFT
+$12.7M
3
V icon
Visa
V
+$7.78M
4
MA icon
Mastercard
MA
+$4.67M
5
AMAT icon
Applied Materials
AMAT
+$4.67M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$16M
2
IDXX icon
Idexx Laboratories
IDXX
+$2.62M
3
ADBE icon
Adobe
ADBE
+$2M
4
MCD icon
McDonald's
MCD
+$1.75M
5
INTU icon
Intuit
INTU
+$1.63M

Sector Composition

Rank Sector Weight
1 Technology 24.35%
2 Financials 22.24%
3 Consumer Discretionary 18.99%
4 Communication Services 11.15%
5 Healthcare 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLBS icon
1051
Globus Maritime Ltd
GLBS
$76.4M
$46 ﹤0.01%
2
GENE
1052
DELISTED
Genetic Technologies Ltd.
GENE
$46 ﹤0.01%
4
ELOX
1053
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
0
CRIS icon
1054
Curis
CRIS
$3.61M
0
QCLS
1055
Q/C Technologies Inc
QCLS
$19.2M
0
TMUSR
1056
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
$25 ﹤0.01%
+150
New +$42
BLRX
1057
BioLineRX
BLRX
$11.4M
0
FAZ
1058
Direxion Daily Financial Bear 3x ETF
FAZ
$88.2M
0
LSTA icon
1059
Lisata Therapeutics
LSTA
$15.2M
$18 ﹤0.01%
1
SNOA icon
1060
Sonoma Pharmaceuticals
SNOA
$6.27M
0
GRCE
1061
Grace Therapeutics
GRCE
$44.6M
$14 ﹤0.01%
1
TPST icon
1062
Tempest Therapeutics
TPST
$17.5M
0
GTE icon
1063
Gran Tierra Energy
GTE
$349M
$10 ﹤0.01%
3
MBOT icon
1064
Microbot Medical
MBOT
$99.4M
$7 ﹤0.01%
1
CRC
1065
DELISTED
California Resources Corporation
CRC
$6 ﹤0.01%
5
OIBR.C
1066
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$4 ﹤0.01%
4
APEN
1067
DELISTED
Apollo Endosurgery, Inc.
APEN
$2 ﹤0.01%
1
ADXS
1068
DELISTED
Advaxis Inc
ADXS
$2 ﹤0.01%
4
OPTT icon
1069
Ocean Power Technologies
OPTT
$46.2M
$1 ﹤0.01%
2
ABEV icon
1070
Ambev
ABEV
$44.1B
-790
Closed -$1.82K
AFL icon
1071
Aflac
AFL
$58.4B
-380
Closed -$13K
AGQ icon
1072
ProShares Ultra Silver
AGQ
$1.52B
-1,139
Closed -$21K
BBWI icon
1073
Bath & Body Works
BBWI
$3.88B
-139
Closed -$1.29K
BEP icon
1074
Brookfield Renewable
BEP
$9.52B
-310
Closed -$7.01K
DOC icon
1075
Healthpeak Properties
DOC
$14.5B
-300
Closed -$7.16K

Similar funds

RBC Europe's Q2 2020 Portfolio in Review

As of Q2 2020, RBC Europe held 1,109 positions worth $1.29B, up 29% from $1B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

RBC Europe deployed $53.6M of net new capital in Q2 2020, opening 59 new positions and adding to 171 existing holdings. Its largest new stake was S&P Global: 6,016 shares worth $1.98M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $16M trimmed.

  • RBC Europe's largest Q2 2020 buy was S&P Global: 6,016 shares worth $1.98M.
  • RBC Europe added most to Berkshire Hathaway Class B in Q2 2020, an estimated $13.2M increase.
  • RBC Europe's biggest Q2 2020 reduction was Tesla, cutting an estimated $16M.
  • RBC Europe fully exited Raytheon Company in Q2 2020, selling an estimated $558K.
  • RBC Europe's ten largest holdings make up 55% of its $1.29B portfolio in Q2 2020.
  • RBC Europe opened 59 new positions and closed 40 in Q2 2020.
  • RBC Europe's portfolio value rose 29% quarter-over-quarter to $1.29B.

Based on RBC Europe's 13F filing for Q2 2020, filed 9 Nov 2023.